ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $283,000 | +89.9% | 194,032 | +84.8% | 0.01% | +100.0% |
| Q4 2016 | $149,000 | -36.1% | 105,012 | -23.0% | 0.00% | -20.0% |
| Q2 2016 | $233,000 | +128.4% | 136,462 | +162.6% | 0.01% | +66.7% |
| Q1 2016 | $102,000 | -44.0% | 51,965 | -45.6% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | +29.1% | 95,548 | +29.5% | 0.00% | +50.0% |
| Q3 2015 | $141,000 | +11.9% | 73,785 | +171.3% | 0.00% | 0.0% |
| Q2 2015 | $126,000 | -13.7% | 27,201 | -18.6% | 0.00% | -33.3% |
| Q1 2015 | $146,000 | +71.8% | 33,423 | +37.2% | 0.00% | +200.0% |
| Q4 2014 | $85,000 | -49.7% | 24,368 | -15.3% | 0.00% | -66.7% |
| Q2 2014 | $169,000 | +65.7% | 28,763 | +77.9% | 0.00% | +200.0% |
| Q1 2014 | $102,000 | +8.5% | 16,172 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $94,000 | -66.2% | 16,141 | -69.4% | 0.00% | -75.0% |
| Q3 2013 | $278,000 | – | 52,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |